We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

1 hedge funds and large institutions have $65K invested in Loxo Oncology, Inc in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 231 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 232 → 1 (-231)

100% less funds holding in top 10

Funds holding in top 10: 7 → 0 (-7)

100% less capital invested

Capital invested by funds: $4.15B → $65K (-$4.15B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 231

Holders
1
Holders Change
-231
Holders Change %
-99.57%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
231
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$391M
2
BlackRock
BlackRock
New York
-$319M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$296M
4
AC
Aisling Capital
New York
-$286M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$280M
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
76
Swiss National Bank
Switzerland
– -$5.66M -40,400 Closed
California Public Employees Retirement System
77
California Public Employees Retirement System
California
– -$5.58M -39,872 Closed
RhumbLine Advisers
78
RhumbLine Advisers
Massachusetts
– -$5.29M -37,751 Closed
NIP
79
Nicholas Investment Partners
California
– -$4.47M -31,889 Closed
FCM
80
Frontier Capital Management
Massachusetts
– -$4.44M -31,728 Closed
AQR Capital Management
81
AQR Capital Management
Connecticut
– -$4.41M -31,470 Closed
Marshall Wace
82
Marshall Wace
United Kingdom
– -$4.24M -30,263 Closed
State of Wisconsin Investment Board
83
State of Wisconsin Investment Board
Wisconsin
– -$3.87M -27,600 Closed
GH
84
GAM Holding
Switzerland
– -$3.8M -27,111 Closed
ACM
85
Aquilo Capital Management
California
– -$3.47M -24,750 Closed
TCM
86
Tekla Capital Management
Massachusetts
– -$3.44M -24,595 Closed
GC
87
Guggenheim Capital
Illinois
– -$3.42M -24,432 Closed
Man Group
88
Man Group
United Kingdom
– -$3.41M -24,357 Closed
Capital Fund Management (CFM)
89
Capital Fund Management (CFM)
France
– -$3.17M -22,630 Closed
PAM
90
Panagora Asset Management
Massachusetts
– -$3.12M -22,262 Closed
MOACM
91
Mutual of America Capital Management
New York
– -$3.12M -22,250 Closed
PVAM
92
Pacific View Asset Management
California
– -$3.05M -21,775 Closed
ACM
93
Atika Capital Management
New York
– -$2.94M -21,000 Closed
MAP
94
Moody Aldrich Partners
Massachusetts
– -$2.85M -20,369 Closed
AIMCA
95
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$2.77M -19,800 Closed
Manulife (Manufacturers Life Insurance)
96
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$2.57M -18,317 Closed
PI
97
Putnam Investments
Massachusetts
– -$2.5M -17,819 Closed
AIG
98
American International Group
New York
– -$2.48M -17,708 Closed
QI
99
QS Investors
New York
– -$2.47M -17,656 Closed
EAM
100
Erste Asset Management
Austria
– -$2.33M -17,300 Closed
2 3
4
5 6

LOXO Hedge Fund Activity: Q1 2019 in Review

1 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q1 2019, worth a combined $65K — down 100% from $4.15B a quarter earlier.

Sellers outnumbered buyers: 231 funds closed out of LOXO and 0 opened new positions — a net loss of 231 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $391M sold.

  • 1 institutional investor held Loxo Oncology, Inc (LOXO) as of Q1 2019, down from 232 in Q4 2018.
  • Funds reported $65K of Loxo Oncology, Inc stock for Q1 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Loxo Oncology, Inc positions in Q1 2019 and 231 closed out, a net change of -231 holders.
  • The largest Loxo Oncology, Inc seller in Q1 2019 was Vanguard Group, an estimated $391M sold.

Based on aggregated 13F filings for Q1 2019.